3～4期慢性肾脏病合并高血压265例用药控制情况及影响因素分析

目的了解慢性肾脏病(CKD)3～4期合并高血压患者血压控制情况、治疗现状,分析其影响因素。方法分析2010年4月至2011年4月265例在北京友谊医院CKD门诊规律随访3个月以上的CKD 3～4期合并高血压的患者的临床资料和治疗情况。结果高血压知晓率为97.7%,知道正确靶目标值的患者占83%,血压控制在130/80 mmHg以下的CKD高血压患者占39.2%。服用3种以上降压药物的患者占19.6%,利尿剂使用比例6.8%。结论应加强对CKD合并高血压患者的教育及自我管理的培训,临床医师应给予患者更加积极合理的降压治疗,提高血压控制率,改善预后。

Blood control,current therapeutics and influencing factors in patients with stage 3 and 4 chronic kidney disease complicating with hypertension

Objective To determine the blood control,current therapeutics and influencing factors in patients who had stage 3 and 4 chronic kidney disease(CKD) patients complicating with hypertension. Methods We analyzed the clinical and therapeutic profiles of 265 patients with stage 3 and 4 CKD complicating with hypertension who were followed-up regularly for at least 3 months from the CKD out-patient clinics,Peking Friendship Hospital. Results 97.7% of participants were aware of hypertension and 83% knew the correct target threshold.Blood pressure was maintained below 130/80 mmHg in 39.2% of patients who had stage 3 and 4 CKD complicating with hypertension.Triple medication regimen was prescribed in 19.6% of patients,and 6.8% were on diuretics therapy. Conclusion Education and self-management training in CKD patients complicating with hypertension should be reinforced,and clinicians should be responsible for rational and active anti-hypertensive therapy,thereby improving blood control rate and prognosis.